Literature DB >> 15910181

Effects of photodynamic therapy on peripheral nerve: in situ compound-action potentials study in a canine model.

Kenneth C Dole1, Qun Chen, Fred W Hetzel, Lawrence R Whalen, Dominique Blanc, Zhen Huang.   

Abstract

OBJECTIVE: Our aim is to investigate the effects of photodynamic therapy (PDT) on peripheral nerve conductivity. BACKGROUND DATA: Interstitial PDT has been demonstrated as a promising treatment modality for prostate cancer. However, the sensitivity of nerves, in the immediate vicinity of the prostate gland, to PDT procedures has not been studied. This study attempts to establish an in situ canine model to evaluate direct PDT effect on peripheral nerves.
METHODS: PDT was performed by irradiating the cutaneous branches of the saphenous nerve at 763 nm with light doses of 50-200 J/cm2 after i.v. infusion of the photosensitizer Tookad (0-2 mg/kg). Evoked compound-action potentials (CAP) were recorded directly from the surface of the saphenous nerve. The latencies to onset and conduction velocities were determined during PDT and 1-week post-PDT.
RESULTS: Nerve and surrounding tissue damage corresponded well with drug/light doses. With Tookad doses of 2 mg/kg, treatment with 50 J/cm2 induced little change in saphenous nerve conduction properties. However, treatment with 100 J/cm2 resulted in localized nerve injury and decreases in nerve conduction velocities, and treatment with 200 J/cm2 severely damaged the nerve.
CONCLUSIONS: This canine model adequately demonstrates effects of Tookad PDT on peripheral nerves. Direct irradiation of 100-200 J/cm2 can alter nerve conduction and induce nerve damage. Therefore, possible side effects of interstitial PDT on the pelvic plexus need to be investigated in future studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15910181      PMCID: PMC1365047          DOI: 10.1089/pho.2005.23.172

Source DB:  PubMed          Journal:  Photomed Laser Surg        ISSN: 1549-5418            Impact factor:   2.796


  15 in total

1.  Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation.

Authors:  Zheng Huang; Qun Chen; Nadira Trncic; Susan M LaRue; Pierre-Hervé Brun; Brian C Wilson; Howard Shapiro; Fred W Hetzel
Journal:  Radiat Res       Date:  2004-06       Impact factor: 2.841

2.  Anatomy of the pelvic plexus and innervation of the prostate gland.

Authors:  M Ali; I P Johnson; J Hobson; B Mohammadi; F Khan
Journal:  Clin Anat       Date:  2004-03       Impact factor: 2.414

3.  Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers.

Authors:  Qun Chen; Zheng Huang; David Luck; Jill Beckers; Pierre-Herve Brun; Brian C Wilson; Avigdor Scherz; Yoram Salomon; Fred W Hetzel
Journal:  Photochem Photobiol       Date:  2002-10       Impact factor: 3.421

4.  Photodynamic therapy in the canine prostate using motexafin lutetium.

Authors:  R A Hsi; A Kapatkin; J Strandberg; T Zhu; T Vulcan; M Solonenko; C Rodriguez; J Chang; M Saunders; N Mason; S Hahn
Journal:  Clin Cancer Res       Date:  2001-03       Impact factor: 12.531

5.  Interstitial photodynamic therapy in the canine prostate.

Authors:  L K Lee; C Whitehurst; Q Chen; M L Pantelides; F W Hetzel; J V Moore
Journal:  Br J Urol       Date:  1997-12

6.  Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer.

Authors:  Zheng Huang; Qun Chen; David Luck; Jill Beckers; Brian C Wilson; Nadira Trncic; Susan M Larue; Dominique Blanc; Fred W Hetzel
Journal:  Lasers Surg Med       Date:  2005-06       Impact factor: 4.025

7.  Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate.

Authors:  S H Selman; D Albrecht; R W Keck; P Brennan; S Kondo
Journal:  J Urol       Date:  2001-05       Impact factor: 7.450

8.  Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis.

Authors:  T Momma; M R Hamblin; H C Wu; T Hasan
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

9.  The inferior hypogastric plexus (pelvic plexus): its importance in neural preservation techniques.

Authors:  B Mauroy; X Demondion; A Drizenko; E Goullet; J-L Bonnal; J Biserte; C Abbou
Journal:  Surg Radiol Anat       Date:  2003-04-11       Impact factor: 1.246

10.  Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study.

Authors:  Timothy R Nathan; Douglas E Whitelaw; Stanley C Chang; William R Lees; Paul M Ripley; Heather Payne; Linda Jones; M Constance Parkinson; Mark Emberton; Alison R Gillams; Anthony R Mundy; Stephen G Bown
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

View more
  8 in total

Review 1.  A review of progress in clinical photodynamic therapy.

Authors:  Z Huang
Journal:  Technol Cancer Res Treat       Date:  2005-06

2.  The effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues--in vivo study in a canine model.

Authors:  Zheng Huang; Qun Chen; Kenneth C Dole; Al B Barqawi; Yang K Chen; Dominique Blanc; Brian C Wilson; Fred W Hetzel
Journal:  Photochem Photobiol Sci       Date:  2007-08-22       Impact factor: 3.982

3.  Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer.

Authors:  Zheng Huang; Qun Chen; David Luck; Jill Beckers; Brian C Wilson; Nadira Trncic; Susan M Larue; Dominique Blanc; Fred W Hetzel
Journal:  Lasers Surg Med       Date:  2005-06       Impact factor: 4.025

4.  Peripheral neural cell sensitivity to mTHPC-mediated photodynamic therapy in a 3D in vitro model.

Authors:  K E Wright; E Liniker; M Loizidou; C Moore; A J Macrobert; J B Phillips
Journal:  Br J Cancer       Date:  2009-07-28       Impact factor: 7.640

5.  Effect of drug-light interval on the mode of action of Photofrin photodynamic therapy in a mouse tumor model.

Authors:  Li-Bo Li; Rong-Cheng Luo
Journal:  Lasers Med Sci       Date:  2008-10-21       Impact factor: 3.161

6.  Could clinical photochemical internalisation be optimised to avoid neuronal toxicity?

Authors:  Caitriona O'Rourke; Colin Hopper; Alexander J MacRobert; James B Phillips; Josephine H Woodhams
Journal:  Int J Pharm       Date:  2017-06-01       Impact factor: 5.875

7.  Focal treatment of prostate cancer with vascular-targeted photodynamic therapy.

Authors:  Scott E Eggener; Jonathan A Coleman
Journal:  ScientificWorldJournal       Date:  2008-10-03

Review 8.  Photosensitizers in prostate cancer therapy.

Authors:  Taher Gheewala; Troy Skwor; Gnanasekar Munirathinam
Journal:  Oncotarget       Date:  2017-05-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.